FINWIRES · TerminalLIVE
FINWIRES

Lupin Gets US FDA Approval for Ranluspec Interchangeable Biosimilar for Eyesight Ailments

By

Pharmaceutical company Lupin (NSE:LUPIN, BOM:500257) has received approval from the U.S. Food and Drug Administration for Ranluspec (ranibizumab-hkdz), an interchangeable biosimilar referencing Lucentis of Genentech.

The US FDA has approved Ranluspec in both vials and pre-filled syringes in strengths of 0.3 mg (0.05 mL of 6 mg/mL) and 0.5 mg (0.05 mL of 10 mg/mL).

The drug is used to treat adults with certain sight problems, including neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and myopic choroidal neovascularisation.

Related Articles

Asia

United Paragon Mining Issues 3.2 Billion Shares to Pargold Mining

United Paragon Mining (PSE:UPM) completed the issuance of 3.2 billion common shares to Pargold Mining under its conversion program, according to a Friday Philippines Exchange filing.The shares, with a par value of 0.01 Philippine peso each, were issued in exchange for UPMC's outstanding liabilities as outlined in a May 29 Deed of Assignment.Following the deal, United Paragon Mining's Class A preferred shares were cancelled and converted into common shares.

$PSE:UPM
Asia

AboitizPower Confirms Vietnam Expansion, Van Phong Power Stake Plan

Aboitiz Power (PSE:AP) confirmed details reported by the Philippine Daily Inquirer regarding its planned expansion in Vietnam, including its proposed acquisition of a 25% stake in Van Phong Power.Van Phong Power owns a 1,320-megawatt coal-fired power plant, according to a Friday filing with the Philippine Stock Exchange.The company said the transaction, first disclosed in October 2025, remains subject to regulatory approval.Aboitiz Power also confirmed discussions on cooperation in energy, food security and infrastructure during Vietnamese President To Lam's visit to Manila.The company said it would disclose any material developments as required.

$PSE:AP
Asia

Global Chinese Business Club Expands Into Health and Wellness Sector

Global Chinese Business Club (HKG:1757) has launched two health and wellness brands and established a chain of stores across mainland China, according to a Thursday Hong Kong bourse filing.The company said the business operates under the Wicens and Tofans brands, with outlets in cities including Shenzhen, Beijing, Shanghai, Wuhan, Fuzhou, Chongqing, Shenyang, and Xi'an.

$HKG:1757